Research in Pharmaceutical Sciences · 2022 · 18 citations · 28 references
PharmacyOncologyPharmacologyDrug DesignDrug DiscoveryImmunotherapyAntibody CharacterizationAntibody DiscoveryAntibody Fragment EngineeringAntibody PurificationAntibody StructureCancer ImmunotherapyCircular Dichroism AnalysisPeptide Secondary StructureSingle-chain Variable FragmentsSmall Cell Lung Cancer ImmunotherapySmall Cell Lung Cancer TreatmentTherapeutic Antibody DesignToxin StructureWestern Blotting
Background and purpose: The lack of a new effective treatment for small cell lung cancer (SCLC) is an unresolved problem. Due to the new identification of delta-like ligand 3 (DLL3) and its high expression in SCLC patients, the use of DLL3 in target therapy can be effective. The use of bacterial toxins belonging to the ADP-ribosyl transferase toxins family and human enzymes to remove cancerous cells has been effective in the structure of immunotoxins. In this study, single-chain fragment variable of rovalpituzumab antibody fused to granzyme B (Rova-GrB) and PltA of typhoid toxin (Rova-Typh) as immunotoxins were designed, and bioinformatics analysis was done. Experimental approach: BL21 (DE3) host, purified, subsequently confirmed by western blotting and their secondary structure was evaluated by the circular dichroism method. Findings/Results: The bioinformatics analysis showed that Rova-GrB and Rova-Typh had hydrophilic properties, their codon optimization parameters were standard, validation parameters were improved after immunotoxin refinement, and docking analysis showed that the binding domain of immunotoxins could bind the N-terminal region of DLL3. immunotoxins had high expression and after purification under denaturing condition by Ni-NTA column, the immunotoxins were dialyzed against PBS buffer. Conclusion and implications: The immunotoxins had the right structure and can be produced in a prokaryotic host. The recombinant immunotoxins against DLL3 can be promising therapeutic agents for SCLC cancer.
28
How significant is a protein structure similarity with TM-score = 0.5?
Jinrui Xu, Yang Zhang · Bioinformatics · 2010 · 1.2K citations · Full text
Protein–Sol: a web tool for predicting protein solubility from sequence
Max Hebditch, Manuel Alejandro Carballo‐Amador, Spyros Charonis et al. · Bioinformatics · 2017 · 846 citations · Full text